Overview

Intradermal LPS and Antibiotics

Status:
Completed
Trial end date:
2019-02-23
Target enrollment:
Participant gender:
Summary
Erythromycin and clindamycin are believed to have anti-inflammatory aspects. This study investigates the possible anti-inflammatory effects of erythromycin and clindamycin.
Phase:
N/A
Details
Lead Sponsor:
Centre for Human Drug Research, Netherlands
Collaborators:
Cutanea Life Sciences, Inc.
Maruho Co., Ltd.
Treatments:
Anti-Bacterial Agents
Anti-Inflammatory Agents
Antibiotics, Antitubercular
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Clobetasol
Erythromycin
Erythromycin Estolate
Erythromycin Ethylsuccinate
Erythromycin stearate
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate